Search - tctmd.com

Displaying 81 - 100 of 108

Sort: Relevancy | Date

Presentation TVT 2019

Implementation of Multidisciplinary Team Approach to the Management of Patients with Mitral and Tricuspid Valve Disease

Presenter: Mohanad Hamandi

June 13, 2019

Presentation TVT 2019

Surgery After Failed TAVR: What Does Redo Surgery Look Like in 10 Years? A New Iatrogenic Disease

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

Building Sustainable Programs: Anticipating the Tsunami of Structural Heart Disease

Presenter: Janet Wyman

June 12, 2019

Presentation TVT 2019

The TMTT Inpatient Care Team: Preventing Post-Procedure Catastrophes

Presenter: Marcus Burns

June 12, 2019

Presentation TVT 2019

LAA Occlusion Best Practice Considerations and Challenges

Presenter: Jacqueline Saw

June 12, 2019

Presentation TVT 2019

Echocardiography Pearls for Mitral and Tricuspid Valve Disease

Presenter: Dee Dee Wang

June 12, 2019

Presentation TVT 2019

Decision-Making and Procedural Planning Vignettes: MitraClip, TMVR, and Tricuspid Therapy

Presenter: Jason Rogers

June 12, 2019

Presentation TVT 2019

Nurse-Led Sedation for TAVR

Presenter: Bria Kneller

June 12, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

Presentation TVT 2019

Individualized Care Pathways

Presenter: Sandra Lauck

June 12, 2019

Presentation TVT 2019

Are There Opportunities in Your Valve Program?

Presenter: Sarah Clarke

June 12, 2019

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Francesco Maisano

June 15, 2017

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

Advertisement

Implementation of Multidisciplinary Team Approach to the Management of Patients with Mitral and Tricuspid Valve Disease

Surgery After Failed TAVR: What Does Redo Surgery Look Like in 10 Years? A New Iatrogenic Disease

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Building Sustainable Programs: Anticipating the Tsunami of Structural Heart Disease

The TMTT Inpatient Care Team: Preventing Post-Procedure Catastrophes

LAA Occlusion Best Practice Considerations and Challenges

Echocardiography Pearls for Mitral and Tricuspid Valve Disease

Decision-Making and Procedural Planning Vignettes: MitraClip, TMVR, and Tricuspid Therapy

Nurse-Led Sedation for TAVR

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Individualized Care Pathways

Are There Opportunities in Your Valve Program?

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

TAVR in Perspective Evolution, Impact, and Future Expectations

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content